These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10772527)

  • 1. Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children. Pediatric AIDS Clinical Trials Group Protocol 144 Study Team.
    Stevens RC; Rodman JH; Yong FH; Carey V; Knupp CA; Frenkel LM
    AIDS Res Hum Retroviruses; 2000 Mar; 16(5):415-21. PubMed ID: 10772527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic evaluation of the combination of zidovudine and didanosine in children with human immunodeficiency virus infection.
    Mueller BU; Pizzo PA; Farley M; Husson RN; Goldsmith J; Kovacs A; Woods L; Ono J; Church JA; Brouwers P
    J Pediatr; 1994 Jul; 125(1):142-6. PubMed ID: 8021765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetics Analysis To Inform Efavirenz Dosing Recommendations in Pediatric HIV Patients Aged 3 Months to 3 Years.
    Luo M; Chapel S; Sevinsky H; Savant I; Cirincione B; Bertz R; Roy A
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3676-86. PubMed ID: 27067333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study.
    Wang Y; Livingston E; Patil S; McKinney RE; Bardeguez AD; Gandia J; O'Sullivan MJ; Clax P; Huang S; Unadkat JD
    J Infect Dis; 1999 Nov; 180(5):1536-41. PubMed ID: 10515813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efavirenz Capsule Sprinkle and Liquid Formulations With Didanosine and Emtricitabine in HIV-1-infected Infants and Children 3 Months to 6 Years of Age: Study AI266-922.
    Pavia-Ruz N; Rossouw M; Sáez-Llorens X; Bunupuradah T; Taylor M; Yang R; Sevinsky H; Krystal M; Lataillade M; Seekins D; Biguenet S
    Pediatr Infect Dis J; 2015 Dec; 34(12):1355-60. PubMed ID: 26379163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatment.
    Hirt D; Bardin C; Diagbouga S; Nacro B; Hien H; Zoure E; Rouet F; Ouiminga A; Urien S; Foulongne V; Van De Perre P; Tréluyer JM; Msellati P
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4399-406. PubMed ID: 19581461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of food on the antiviral activity of didanosine enteric-coated capsules: a pilot comparative study.
    Hernández-Novoa B; Antela A; Gutiérrez C; Pérez-Molina JA; Pérez-Elías MJ; Dronda F; Moreno A; Casado JL; Page C; Pumares M; Galán JC; Moreno S
    HIV Med; 2008 Apr; 9(4):187-91. PubMed ID: 18298579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy.
    Fletcher CV; Brundage RC; Remmel RP; Page LM; Weller D; Calles NR; Simon C; Kline MW
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1029-34. PubMed ID: 10722507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
    AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine.
    Kearney BP; Sayre JR; Flaherty JF; Chen SS; Kaul S; Cheng AK
    J Clin Pharmacol; 2005 Dec; 45(12):1360-7. PubMed ID: 16291710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads.
    Damle BD; Yan JH; Behr D; O'Mara E; Nichola P; Kaul S; Knupp C
    J Clin Pharmacol; 2002 Apr; 42(4):419-27. PubMed ID: 11936567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oral ganciclovir capsules in HIV-infected persons.
    Griffy KG
    AIDS; 1996 Dec; 10 Suppl 4():S3-6. PubMed ID: 9110063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abacavir pharmacokinetics in human immunodeficiency virus-infected children ranging in age from 1 month to 16 years: a population analysis.
    Jullien V; Urien S; Chappuy H; Dimet J; Rey E; Pons G; Blanche S; Tréluyer JM
    J Clin Pharmacol; 2005 Mar; 45(3):257-64. PubMed ID: 15703361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food-induced reduction in bioavailability of didanosine.
    Shyu WC; Knupp CA; Pittman KA; Dunkle L; Barbhaiya RH
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):503-7. PubMed ID: 1934863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pharmacokinetic evaluation of long-term therapy with didanosine in children with HIV infection.
    Mueller BU; Butler KM; Stocker VL; Balis FM; Brouwers P; Jarosinski P; Husson RN; Lewis LL; Venzon D; Pizzo PA
    Pediatrics; 1994 Nov; 94(5):724-31. PubMed ID: 7936903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.
    Balis FM; Pizzo PA; Butler KM; Hawkins ME; Brouwers P; Husson RN; Jacobsen F; Blaney SM; Gress J; Jarosinski P
    J Infect Dis; 1992 Jan; 165(1):99-104. PubMed ID: 1727902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.
    McKinney RE; Rodman J; Hu C; Britto P; Hughes M; Smith ME; Serchuck LK; Kraimer J; Ortiz AA; Flynn P; Yogev R; Spector S; Draper L; Tran P; Scites M; Dickover R; Weinberg A; Cunningham C; Abrams E; Blum MR; Chittick GE; Reynolds L; Rathore M;
    Pediatrics; 2007 Aug; 120(2):e416-23. PubMed ID: 17646352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates.
    Rongkavilit C; Thaithumyanon P; Chuenyam T; Damle BD; Limpongsanurak S; Boonrod C; Srigritsanapol A; Hassink EA; Hoetelmans RM; Cooper DA; Lange JM; Ruxrungtham K; Phanuphak P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3585-90. PubMed ID: 11709344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
    Englund JA; Baker CJ; Raskino C; McKinney RE; Petrie B; Fowler MG; Pearson D; Gershon A; McSherry GD; Abrams EJ; Schliozberg J; Sullivan JL
    N Engl J Med; 1997 Jun; 336(24):1704-12. PubMed ID: 9182213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.